Dynorphin-kappa opioid receptor activity in the central amygdala modulates binge-like alcohol drinking in mice
- 11 December 2018
- journal article
- research article
- Published by Springer Nature in Neuropsychopharmacology
- Vol. 44 (6) , 1084-1092
Abstract
Although previous research has demonstrated a role for kappa opioid receptor-mediated signaling in escalated alcohol consumption associated with dependence and stress exposure, involvement of the dynorphin/kappa opioid receptor (DYN/KOR) system in binge-like drinking has not been fully explored. Here we used pharmacological and chemogenetic approaches to examine the influence of DYN/KOR signaling on alcohol consumption in the drinking-in-the-dark (DID) model of binge-like drinking. Systemic administration of the KOR agonist U50,488 increased binge-like drinking (Experiment 1) while, conversely, systemic administration of the KOR antagonist nor-BNI reduced drinking in the DID model (Experiment 2). These effects of systemic KOR manipulation were selective for alcohol as neither drug influenced consumption of sucrose in the DID paradigm (Experiment 3). In Experiment 4, administration of the long-acting KOR antagonist nor-BNI into the central nucleus of the amygdala (CeA) decreased alcohol intake. Next, targeted “silencing” of DYN+ neurons in the CeA was accomplished using a chemogenetic strategy. Cre-dependent viral expression in DYN+ neurons was confirmed in CeA of Pdyn-IRES-Cre mice and functionality of an inhibitory (hM4Di) DREADD was validated (Experiment 5). Activating the inhibitory DREADD by CNO injection reduced binge-like alcohol drinking, but CNO injection did not alter alcohol intake in mice that were treated with control virus (Experiment 6). Collectively, these results demonstrate that DYN/KOR signaling in the CeA contributes to excessive alcohol consumption in a binge-drinking model.Keywords
Funding Information
- U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (F32 AA023700, T32 AA007474, P50 AA10716, U01 AA014095, P50 AA10716, U01 AA014095, P50 AA10716, U01 AA014095, T32 AA007474, F31 AA025835, P60 AA011605, P60 AA011605, U24 AA025475, P60 AA011605, P50 AA10716, U01 AA014095, F32 AA023700, T32 AA007474)
- U.S. Department of Veterans Affairs (BX 000813)
This publication has 59 references indexed in Scilit:
- The neurobiology of binge-like ethanol drinking: Evidence from rodent modelsPhysiology & Behavior, 2012
- Presynaptic Inhibition of Gamma-Aminobutyric Acid Release in the Bed Nucleus of the Stria Terminalis by Kappa Opioid Receptor SignalingBiological Psychiatry, 2012
- Central Neuropeptide Y Modulates Binge-Like Ethanol Drinking in C57BL/6J Mice via Y1 and Y2 ReceptorsNeuropsychopharmacology, 2012
- Corticotropin Releasing Factor–Induced Amygdala Gamma-Aminobutyric Acid Release Plays a Key Role in Alcohol DependenceBiological Psychiatry, 2010
- The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abusePsychopharmacology, 2010
- CRF-1 Antagonist and CRF-2 Agonist Decrease Binge-Like Ethanol Drinking in C57BL/6J Mice Independent of the HPA AxisNeuropsychopharmacology, 2010
- The dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviorsBrain Research, 2010
- A Line of Mice Selected for High Blood Ethanol Concentrations Shows Drinking in the Dark to IntoxicationBiological Psychiatry, 2009
- Pharmacological Evidence for a Motivational Role of κ-Opioid Systems in Ethanol DependenceNeuropsychopharmacology, 2007
- Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligandProceedings of the National Academy of Sciences, 2007